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Recurrent stenosis occurring within 2 years after
carotid endarterectomy is usually caused by myointi-
mal hyperplasia.1-4 Some of these stenoses will
progress to hemodynamic significance, some will
occlude, and neurologic symptoms or complications
will develop in a few patients.2,5-9 However, most
patients with recurrent early stenosis are asympto-
matic and follow a benign clinical course.2,5,6,10,11
Also, many of these lesions will remain stable or even
regress8,10,12; however, the natural history of this
remodeling process has not been well studied. Our
experience with two critical (more than 80%) recur-
rent stenoses that spontaneously resolved prompted
a retrospective evaluation of our total experience
with early recurrent hemodynamically significant
restenoses. Specific attention was directed at defin-
ing the incidence and clinical implications of
restenosis regression.
METHODS
The computerized vascular laboratory database
(Atrium Vaslab, Atrium Medical, Hudson, NH) and
vascular registry (Atrium Registry) of a six-surgeon
community vascular practice on the West Coast of
Florida were queried to recall all patients in whom a
hemodynamically significant early recurrent carotid
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stenosis had developed. A stenosis was considered to
be early when it manifested within 2 years of carotid
endarterectomy but was not present on at least one
postendarterectomy duplex surveillance scan. A
stenosis was considered to be hemodynamically sig-
nificant when the internal carotid artery peak systolic
velocity was greater than 125 cm/s. Specifically
excluded was the one patient who had evidence of
residual stenosis demonstrated by means of the first
postendarterectomy duplex scan, which was usually
performed 1 month after surgery. Patients whose
recurrent stenosis followed surgery that was not per-
formed by one of the group’s surgeons were also
excluded from this review. 
Most original endarterectomies were performed
in a similar manner. General anesthesia was used
routinely. Cerebral monitoring was not used, and
shunts were never inserted. Tacking sutures were
rarely required. Primary closure was achieved with
6-0 polypropylene suture. Patches were rarely used
in the early phase of this review. However, in the last
5 years, prosthetic patches (Meadox Hemashield)
have been used for arteries measuring less than 3.5
mm or when very high dissection was required.
Intraoperative duplex scanning or angiography was
not performed. Patients were maintained on aspirin
postoperatively.
Only patients who had at least two scans after
endarterectomy were included. All patients had been
entered into a postoperative surveillance program
that included a complete neurological history and
color duplex scan (Acuson, Mountainview, Calif)
performed within 1 month after surgery and then on
a 6-month schedule for 2 years. Patients who had
recurrent stenosis of more than 50% after 2 years or
those with a contralateral more than 50% lesion were
examined on an ongoing 6-month schedule. If after
2 years the stenosis on either side was less than 50%,
scans were performed yearly. Although we tried to
adhere to a strict schedule, patient unavailability and
insurance considerations often necessitated that the
scans be performed at times other than those man-
dated by the protocol. Scans were also performed
when new neurological symptoms were suspected.
The scans were performed by four technologists
(three registered vascular technologists) in an
Intersocietal Commission on the Accreditation of
Vascular Laboratories (ICAVL) certified laboratory,
under the direction of a registered vascular technol-
ogist surgeon. The overall accuracy of scans per-
formed in this laboratory was 98%.
These hemodynamically significant stenoses were
then classified into four groups according to the
maximal velocity recorded: group I, systolic velocity
more than 125 cm/s and less than 280 cm/s; group
II, systolic velocity more than 280 cm/s or diastolic
velocity more than 80 cm/s; group III, systolic
velocity more than 280 cm/s and diastolic velocity
more than 120 cm/s; and group IV, internal carotid
artery occlusion. In our practice, these groups cor-
relate with 50% to 59% stenosis, 60% to 79% steno-
sis, 80% to 99% stenosis, and 100% stenosis, respec-
tively. The time to a velocity of more than 125 cm/s
(TT more than 50%) was calculated, as was time to
peak maximal systolic velocity (TTP). When regres-
sion occurred, the time to a 20% decrease in systolic
velocity (TT less than 20%) and time to lowest sys-
tolic velocity (TTL) were also recorded. All neuro-
logical events were noted, and the date and method
of redo surgery, when applicable, were recorded.
The use of patches during the original endarterecto-
my was also evaluated. 
RESULTS
Recurrent hemodynamically significant stenosis
occurred in 49 internal carotid arteries (45 patients, 25
men and 20 women) after 883 endarterectomies
(5.4%) that had been followed for at least 6 months
(Fig 1). The incidence was higher in women than men
(6.5% vs. 4.4%). Risk factors for atherosclerosis were
similar to those reported in other series (diabetes, 42%;
hypertension, 64%; coronary artery disease, 58%;
smoking, 76%). By definition, all patients in whom
such a recurrence was diagnosed had at least one nor-
mal postendarterectomy scan. The follow-up period
was 6 to 87 months (mean, 40 months), and the
median number of postendarterectomy scans was four.
Nine of the 49 recurrences were followed for less than
18 months, four because they underwent redo
endarterectomy within that time frame. Recurrent
stenosis was noted in 28 right-side and 20 left-side
carotid arteries. Thirty-three percent of all endarterec-
tomies had been patched, yet only 10% (five) of the
recurrences occurred in patched arteries. Asymp-
tomatic stenosis was the primary indication for the
original endarterectomy in most patients (61%). 
Based on duplex surveillance results, the
restenoses were classified as follows: group I (12);
group II (21); group III (14); and group IV (2).
Patients were observed for a mean of 53 months
(range, 9 to 84 months). The mean TT more than
125 cm/s was 11 months (range, 6 to 24 months).
The mean TTP was 16 months (range, 6 to 44
months). 
The long-term follow-up is graphically repre-
sented in the flow chart in Fig 1. During follow-up,
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five stenoses remained stable (three in group I, one
in group II, and one in group III). Once a lesion
remained stable, ie, no significant increase in veloci-
ty in three consecutive scans, it did not progress. In
19 lesions, systolic velocity continued to increase
during the follow-up period. Two of these are
included in group IV (4%), when asymptomatic
occlusion occurred at 9 and 14 months after endar-
terectomy. Six of these ultimately required redo
“endarterectomy,” two for symptoms and four for
an asymptomatic restenosis of more than 80%. Three
of these latter patients had a contralateral internal
carotid artery occlusion. When redo surgery was
performed, a myointimal lesion that was left in situ
was confirmed by means of surgical exploration.
Treatment was accomplished with Dacron patch
angioplasty without endarterectomy. Recurrent
restenosis has developed in three patients (follow-up,
6 months to 6 years). The mean length of follow-up
for those 11 carotid arteries demonstrating increas-
ing velocities without subsequent redo “endarterec-
tomy” or occlusion was 26 months (range, 9 to 50
months). All were originally noticed while they were
group I lesions. Ultimately, three remained group I
lesions, five remained group II lesions, and three
remained group III lesions, although velocity profiles
were at the upper limit for each classification.
Because the three patients in group III had signifi-
cant medical risk factors for redo surgery, were
asymptomatic, and had minimal contralateral disease,
a nonoperative approach was followed. No other
patient had new neurological symptoms. 
In 25 arteries (53%), velocity profile decreased
by at least one group classification (group I, 6;
group II, 15; and group III, 4; Figs 2 and 3).
Systolic velocity ultimately fell below 125 cm/s in
13 arteries (group I, 6; group II, 5; group III, 2).
The two patients in group III are illustrative of self-
reversal. By definition, all patients in this study
group had a normal postoperative scan. One patient
then demonstrated a peak systolic velocity of 484
cm/s and peak diastolic velocity of 126 cm/s at 12
months. In the ensuing 5 years, her systolic and dias-
tolic velocities fell to 111 and 27 cm/s, respectively.
The other lesion occurred in a patched artery at 1
year and reached a peak systolic velocity of 408 cm/s
and peak diastolic velocity of 157 cm/s at 30
months. In the ensuing 5 years, velocities fell to 124
cm/s and 25 cm/s. 
The mean time to the lowest velocity (TTL) was
50 months. In 24 of these 25 arteries, once a steno-
sis demonstrated a reduction in velocity of at least
20%, it never increased again during subsequent
scans. The mean TT less than 20% was 30 months
(range, 10 to 67 months). In one patient, however,
we noted a trend toward increasing stenosis starting
3 years after it had reached its lowest velocity profile
and 6 years after the original endarterectomy. Grey-
scale imaging suggests that this is new atherosclerot-
ic plaque. 
DISCUSSION
Stoney and String1 first highlighted the clinical sig-
nificance of recurrent carotid stenosis in 1976. Since
then, there have been numerous reports on the sub-
ject.2-16 However, despite the attention given to this
Fig 1. Flow chart showing the original grouping and ultimate outcome for all 49 lesions.
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problem, many questions remain unanswered. In part,
this is caused by a lack of uniform criteria for defining
what constitutes a restenosis. For example, many
reports also include residual defects or immediate
postendarterectomy hemodynamic aberrations that
strictly should not be considered as recurrent stenoses.
Carballo et al6 analyzed a group of patients similar to
ours (619 endarterectomies in 587 patients). Patients
with normal results on intraoperative duplex had a
5.6% incidence of recurrent stenosis, compared with
19% when a residual hemodynamic abnormality was
noted. However, we have specifically excluded patients
Fig 3. Color flow duplex scan of patient in Fig 2, 3 years later. Note normal spectral pattern,
with normal internal carotid systolic velocity of 107 cm/s. Color flow and gray scale also
appear normal.
Fig 2. Color flow duplex scan of a patient with a grade III early recurrence. Note the inter-
nal carotid artery systolic velocity of 285 cm/s, with significant spectral broadening. Color
flow shows turbulent flow.
in whom a defect was noted on the first scan, which
was performed 1 month after endarterectomy. Thus,
we believe that we have largely excluded patients who
would have had an abnormal intraoperative duplex
scan. The one patient whom we excluded from the
study because the stenosis was encountered at the first
follow-up duplex scan at 1 month, had an asympto-
matically occluded carotid artery by 3 months. 
The criteria used to define clinical significance
also vary. Many of the early reports use spectral
changes, rather than velocity parameters, to classify
stenosis. Further, recent advances in ultrasound
scanning technology and accreditation of vascular
laboratories make some of the earlier reports less
reliable. Accordingly, it is not surprising that the
incidence of significant recurrent carotid stenosis is
reported as occurring after 1.1% to 36% of carotid
endarterectomies.6,8 This wide variance is also
caused by the reported incidences including early as
well as late restenoses. It has been suggested that,
taking all these factors into account, the clinically
important incidence of all recurrent stenosis ranges
between 10% and 15%, and only a third of these
become symptomatic or require redo operation.13
This has prompted many to reevaluate the cost-
effectiveness of regular postoperative duplex surveil-
lance programs such as the one used in our prac-
tice.5,9,11,14
The clinical issues associated with restenosis are
complicated by the finding that there may be two dis-
tinct forms of restenosis based on the temporal rela-
tionship to the original endarterectomy. Restenosis
occurring late, ie, more than 2 years after endarterec-
tomy, is most likely caused by recurrent atherosclerosis
and, as such, may pose a higher risk of neurological
complications. On the other hand, histologic studies
show that early lesions are usually attributable to
myointimal hyperplasia and are generally smooth and
regular.2 As such, they pose little threat for emboliza-
tion and accordingly rarely cause symptoms until
high-grade stenosis results.7,13 Questions still remain
about whether early myointimal lesions subsequently
degenerate into atherosclerotic lesions, as may have
been found in one of our patients. The clinical signif-
icance of early recurrent stenosis is also complicated
by the finding that remodeling that will ultimately
cause a reduction in the degree of stenosis can
occur.5,8,12,15 Accordingly, we believe that the early
recurrent lesion should be considered a specific enti-
ty. As such, its natural history must be clearly identi-
fied before clinical decisions can be made safely. 
It is difficult to find data on the evolution or
devolution of such stenoses, because most reports
mix early with late recurrences. Healy et al15 found
a recurrence rate of 26% and regression of recur-
rence in 7%. However, early and late recurrence and
hemodynamic and non-hemodynamic lesions were
grouped together. Also, they do not classify the
lesions that regressed according to the original and
ultimate degree of stenosis. They state that symptom-
atic recurrent stenosis occurs in 4% of patients. In an
older study that used spectral frequency changes to
define stenotic ranges, Bernstein et al12 reported on
a series of 49 recurrent stenoses after 566 carotid
endarterectomies, most of which were early. They
found the incidence of more than 50% restenosis to
be 14.5% in women and 7.7% in men. This female
preponderance has been reported by other authors,7
but was not as clearly defined in our series (6.5%
women, 4.4% men). This difference may be attrib-
uted to our exclusion of immediately discovered
stenoses, which may result from technical considera-
tions in dealing with the smaller female internal
carotid artery. Although only two arteries progressed
to occlusion in our study, Bernstein et al12 found
eight occlusions, all occurring within the first 12
months. Again, this may be caused by the inclusion
of stenoses related to technical error in the perfor-
mance of the endarterectomy. They found regression
in seven stenoses, but do not classify them as being
early or late, nor do they describe the peak or ulti-
mate degree of stenosis reached by these lesions. 
Sanders et al8 examined 94 patients with duplex
and intravenous digital subtraction angiography.
Again, because this was an older study, spectral char-
acteristics were used as means of assessing diameter
changes and residual lesions were included in the
analysis. In patients with less than 50% stenosis,
regression was common, with half of those showing
an abnormality at 3 months normalizing by 1 year.
Seven more than 50% restenoses (7%) were identi-
fied by 12 months, but three were present on intra-
venous digital subtraction angiography 1 week after
surgery. One of these spontaneously regressed, and
one was reoperated. 
Ricotta et al9 followed a philosophy of observa-
tion for asymptomatic recurrent stenosis regardless of
the severity of the lesion. They reserved reoperation
for ipsilateral symptomatic restenosis only. They also
included residual lesions and considered a recurrence
to be present only when it occurred after 36 months.
As a consequence, it is difficult to extrapolate infor-
mation that is germane to a discussion limited to
early lesions as defined by our study. However, a
striking finding in their review, as well as ours, was
the relatively benign and stable nature of the lesions
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detected, despite their severity. Of 18 recurrent
stenoses more than 80% encountered after 449
endarterectomies, only four subsequently developed
symptoms 48 to 103 months after surgery. 
In contrast to these reports, we have limited our
evaluation strictly to patients in whom early recur-
rences that were not a direct result of remnant plaque
or stenosis resulting from a technical defect have
developed. Although we do not have histological
specimens, operative evaluation when redo surgery
was performed and duplex evidence of smooth
homogeneous narrowing suggests that we were usu-
ally dealing with a hyperplastic lesion (Fig 2). This
pathological entity is often associated with an ongo-
ing history of smoking,3,12 and this association
occurred in our series, with 76% of patients admitting
to continued smoking. It has been proposed that
patching the carotid at the original endarterectomy
can prevent these lesions.13 In fact, only five (10%) of
these recurrences occurred in an artery that was
patched. This should be compared with our overall
experience with carotid endarterectomy, in which
33% were patched. However, our early experience, in
which patches were used rarely, overwhelms our
recent experience, in which patches are being used
more frequently. It will be interesting to see whether
this change in surgical technique will impact the inci-
dence of early restenosis in our practice. 
The mean time to developing a more than 50%
stenosis was 11 months. Maximal stenosis was usual-
ly reached by 16 months, but in 11 lesions, increas-
ing stenosis was still noted at a mean of 24 months
(range, 9 to 50 months). Reports already cited sug-
gest that these lesions will most likely behave in a
benign manner; however, it is conceivable that with
longer follow-up some of these could progress fur-
ther or become symptomatic, requiring redo
endarterectomy. Once a lesion remained stable, ie,
no significant increase in velocity in three consecu-
tive scans, it did not progress. Once peak systolic
velocity started to decline by more than 20%, it
never increased again, except in one patient, when 3
years after reaching its nadir, it again started to
increase. Grey-scale duplex findings suggested that
this was atherosclerotic degeneration of the myoin-
timal lesion. Our use of a 20% reduction in systolic
velocity as a predictor of plaque stability may be
arbitrary. Clearly, this number will be related to the
absolute peak systolic velocity, with more significant
lesions requiring a larger drop in velocity to satisfy
this requirement. Furthermore, variations in veloci-
ty could be ascribed to intraobserver and interob-
server variability. However, the overall accuracy of
our laboratory is 98%, and every week we perform
scans on the same patient with different machines
and by different technologists to maintain a high
quality of reliability. However, we acknowledge that
longer follow-up of larger numbers of lesions may be
required to support this finding. 
The relatively benign course of this condition is
again reemphasized by our experience. There were
two occlusions, which although asymptomatic,
should be considered as a potentially serious out-
come. We found only two symptomatic early hemo-
dynamically significant lesions, both of which
required redo surgery. There were also four reoper-
ations for high-grade lesions that might have
become symptomatic. Accordingly, eight of the
lesions (16.3%) could be considered to be clinically
significant. Thus, taken in the context of all the pri-
mary endarterectomies, only 0.9% resulted in an
early stenosis that had a negative outcome. 
CONCLUSION
Despite the tendency for reports on recurrent
carotid stenosis to group residual, early, and late
stenoses together, it does appear that true early
restenosis should be considered to be a separate enti-
ty. Its incidence in our series was 5.4% and usually
reached hemodynamic significance (more than 50%)
by 1 year and maximal stenosis within 16 months of
the original endarterectomy. Rarely, some lesions pro-
gressed to symptoms or occlusion (8.2%). However,
at least half of the lesions regressed. Even critical
restenosis of more than 80% can regress to the point
of normalizing. 
We do not believe that our data can answer some
of the important clinical questions that still remain,
such as which lesion will occlude or become symp-
tomatic. However, the relatively benign clinical
course suggests that a conservative approach can
usually be followed. Once a stenosis has demon-
strated stability for 18 months or has started to
regress, it almost never poses a clinical threat. Our
data also suggest that the postendarterectomy sur-
veillance schedule can be modified. Although some
would suggest that it is not cost effective, we would
favor retaining an ipsilateral surveillance program,
but modifying it according to guidelines learned
from our data. If intraoperative duplex scanning is
not performed, then a scan at 1 month should be
performed as a means of identifying the residual
lesion that may behave more aggressively. When a
stenotic lesion is not shown by means of this scan,
the next study can safely be performed after 1 year.
Once a more than 50% recurrence is found, studies
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should be performed every 6 months. If regression
or stability is encountered, yearly studies can be
resumed or even avoided entirely. Redo surgery
should be reserved for symptomatic patients or
those in whom preservation of a patent artery is of
critical importance, ie, those patients with a con-
tralateral occlusion.
REFERENCES
1. Stoney RJ, String ST. Recurrent carotid stenosis. Surgery
1976;80:705-10. 
2. Sterpetti AV, Schultz RD, Feldhaus RJ, et al. Natural history
of recurrent carotid artery disease. Surg Gynecol Obstet
1989;168:217-23.
3. Claggett GP, Rich NM, McDonald PT, et al. Etiologic fac-
tors for recurrent carotid artery stenosis. Surgery 1983;
93:313-8.
4. Bartlett FK, Rapp JH, Goldstone J, et al. Recurrent carotid
stenosis: Operative strategy and late results. J Vasc Surg
1987;5:452-6.
5. Mattos MA, van Bemmelen PS, Barkmeier LD, et al. Routine
surveillance after carotid endarterectomy: Does it affect clin-
ical management? J Vasc Surg 1993;17:819-31.
6. Carballo RE, Towne JB, Seabrook GR, et al. An outcome
analysis of carotid endarterectomy: The incidence and natu-
ral history of recurrent stenosis. J Vasc Surg 1996;23:749-54.
7. Chervu A. Recurrent carotid artery stenosis: Diagnosis, man-
agement and prevention. Semin Vasc Surg 1995;8:70-6.
8. Sanders EACM, Hoenefeld H, Eikelboom BC, et al. Residual
lesions and early recurrent stenosis after carotid endarterec-
tomy: A serial follow-up study with duplex scanning and
intravenous digital subtraction angiography. J Vasc Surg
1987;5:731-7.
9. Ricotta JJ, O’Brian MS, DeWeese JA. Natural history of
recurrent and residual stenosis after carotid endarterectomy:
Implications for postoperative surveillance and surgical man-
agement. Surgery 1992;112:656-63.
10. Washburn WK, Mackey WC, Belkin M, et al. Late stroke after
carotid endarterectomy: The role of recurrent stenosis. J Vasc
Surg 1992;15:1032-7.
11. Naylor AR, John T, Howlett J, et al. Surveillance imaging of
the operated artery does not alter clinical outcome following
carotid endarterectomy. Br J Surg 1996;83:522-6.
12. Bernstein EF, Torem S, Dilley RB. Does carotid restenosis
predict an increased risk of late symptoms, stroke or death?
Ann Surg 1990;21:629-36.
13. Mansour A. Recurrent carotid stenosis: Prevention, surveil-
lance and management. Semin Vasc Surg 1998;11:30-5.
14. Cook JM, Thompson BW, Barnes RW. Is routine duplex
examination after carotid endarterectomy justified? J Vasc
Surg 1990;12:334-40.
15. Healy DA, Zierler RE, Nichols SC, et al. Long-term follow-
up and clinical outcome of carotid restenosis. J Vasc Surg
1989;10:662-9.
16. Zbornikova V, Elfstrom J, Lassvik C, et al. Restenosis and
occlusion after carotid surgery assessed by duplex scanning and
digital subtraction angiography. Stroke 1986;17:1137-42.
Submitted Oct 22, 1998; accepted Jun 11, 1999.
Dr Robert W. Barnes (Little Rock, Ark). With this
large series of Dr Samson’s, in the past 32 years there have
been 161 publications on recurrent carotid stenosis.
In more than 62,000 carotid endarterectomies, the
incidence of carotid restenosis has averaged 6%, ranging
from 0% to 50%. The mean incidence of carotid restenosis
detected noninvasively is 9%, more than four times the 2%
incidence of symptomatic recurrent stenosis. Restenosis
develops in 12% of arteries closed primarily, versus 5% of
those closed with a patch.
Residual stenoses or occlusions occurring within 1
month of operation account for approximately 20% of
carotid restenoses. Early restenoses, occurring within the
first 2 years, comprise about 50%, and the remaining 30%
of restenoses are late, occurring more than 2 years after
operation. Less than 25% of carotid restenoses ever
become symptomatic, and only 7% ever cause stroke.
However, of the 50% of reported recurrent carotid
stenoses that have been reoperated on, perioperative stroke
has occurred in 5% and death in 1.5%. Only 23 of the 161
articles published to date have reported regression of
carotid restenoses, which has occurred in about 20% of
cases.
Although I agree that some recurrent carotid stenoses
can regress, I am not concerned.
Since the report by Jay Cook to this association 9 years
ago, there have been nine studies that support our con-
tention that the natural history of patients with asymptom-
atic carotid restenosis without reoperation is no worse than
that of patients in whom restenosis does not develop.
Dr Samson, you report only a 0.2% incidence of symp-
tomatic recurrent carotid stenosis. My question is how can
you justify any routine noninvasive surveillance after carotid
endarterectomy? Even if we accept your 0.9% incidence of
so-called “clinically significant” recurrent stenosis, the esti-
mated cost of screening 883 patients in your mean follow-
up period of 53 months would be $250,000 for each lesion
detected, and this does not include the cost of reoperations,
half of which resulted in a second restenosis in your series.
My recommendation is to follow these patients clinical-
ly and reoperate only if symptoms, which are uncommon
and which are usually manifested by transient ischemic
attacks and not stroke, develop. We and other vascular sur-
geons have found this strategy to be applicable to contralat-
eral carotid disease.
Thank you.
DISCUSSION
